Literature DB >> 19288030

Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus.

Tetsuro Yoshida1, Kimihiko Kato, Kiyoshi Yokoi, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Takao Suzuki, Yoshinori Nozawa, Yoshiji Yamada.   

Abstract

Although diabetes mellitus has been recognized as a risk factor for chronic kidney disease (CKD), genetic factors for predisposition to CKD in individuals with diabetes mellitus remain elucidated. The purpose of the present study was to identify genetic variants that confer susceptibility to CKD among individuals with type 2 diabetes mellitus. The study population comprised 1742 Japanese individuals, including 636 subjects with CKD [estimated glomerular filtration rate (eGFR)<60 ml/min/1.73 m2] and 1106 controls (eGFR>or=60 ml/min/1.73 m2). The genotypes for 24 polymorphisms of 22 candidate genes were determined. An initial screen of allele frequencies by the Chi-square test revealed that four polymorphisms were significantly (false discovery rate<0.05) associated with the prevalence of CKD in individuals with type 2 diabetes mellitus. Subsequent multivariable logistic regression analysis with adjustment for covariates as well as a stepwise forward selection procedure revealed that the 8733T-->C polymorphism of ALOX5AP (rs3803278), the C-->T (Ser532Leu) polymorphism of IRAK1 (rs1059703), and the 2445G-->A (Ala54Thr) polymorphism of FABP2 (rs1799883) were significantly (P<0.05) associated with the prevalence of CKD. Our results suggest that ALOX5AP, IRAK1, and FABP2 are susceptibility loci for CKD among Japanese individuals with type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288030     DOI: 10.3892/ijmm_00000161

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

Review 1.  Eicosanoids, β-cell function, and diabetes.

Authors:  Pengcheng Luo; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-03       Impact factor: 3.072

2.  Synergistical action of the β2 adrenoceptor and fatty acid binding protein 2 polymorphisms on the loss of glomerular filtration rate in Chinese patients with type 2 diabetic nephropathy.

Authors:  Tao Wang; Yan Zhang; Ning Wang; Qiong Liu; ZeKai Wang; Bing Liu; Kai Niu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

3.  Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury.

Authors:  Irina A Leaf; Shunsaku Nakagawa; Bryce G Johnson; Jin Joo Cha; Kristen Mittelsteadt; Kevin M Guckian; Ivan G Gomez; William A Altemeier; Jeremy S Duffield
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

4.  Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.

Authors:  Qurrat ul Ain; Nigel H Greig; Muhammad S Nawaz; Sajid Rashid; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

5.  Association of a polymorphism of BTN2A1 with chronic kidney disease in individuals with or without hypertension or diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Mitsutoshi Oguri; Hideki Horibe; Toshiki Kawamiya; Kiyoshi Yokoi; Tetsuo Fujimaki; Sachiro Watanabe; Kei Satoh; Yukitoshi Aoyagi; Masashi Tanaka; Hiroto Yoshida; Shoji Shinkai; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Exp Ther Med       Date:  2011-01-13       Impact factor: 2.447

6.  Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

7.  PECAM-1 Leu125Val (rs688) Polymorphism and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus.

Authors:  Matej Završnik; Stojan Kariž; Jana Makuc; Maja Šeruga; Ines Cilenšek; Daniel Petrovič
Journal:  Anal Cell Pathol (Amst)       Date:  2016-12-28       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.